Gianturco-Rosch biliary stents: preliminary experience.
Results of long-term follow-up are reported for nine patients who underwent placement of Gianturco-Rosch expandable metallic stents. Seven patients had malignant disease. The average duration of patency was 7 months. In one patient with inactive primary sclerosing cholangitis (PSC), the stents remained patent at 22 months, but recurrent stent closure was seen in a second patient with PSC. In the patient population studied, no advantages were seen with use of the stents; however, they may have an application in certain patients with benign disease.
Martin
E C
EC
Department of Radiology, College of Physicians and Surgeons, Columbia University, Columbia-Presbyterian Medical Center, New York, NY 10032.
Laffey
K J
KJ
Bixon
R
R
Getrajdman
G I
GI
D002759:Adenoma, Bile Duct / Q000150:complications* / Q000453:epidemiology; D001661:Biliary Tract Neoplasms / Q000150:complications* / Q000453:epidemiology / Q000556:secondary; D002779:Cholestasis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D015607:Stents